0 items USD 0.00Search
Your search for "Generic Drugs" gave back 14469 results.
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Generic Drugs Report by Material,...
颁补迟补濒辞驳:听
9Dimen Research
February 2023
Price: USD 3,200.00
Summary Inhalation and Nasal Spray Generic Drugs 91制片厂 report provides the newest industry data and industry future trends, allowing you to...
颁补迟补濒辞驳:听
ICRW
March 2021
Price: USD 2,960.00
The global Remicade (infliximab) Drug market size was valued at USD 2623.8 million in 2023 and is forecast to a readjusted size of USD 3781.3 million...
颁补迟补濒辞驳:听
GIR
July 2024
Price: USD 3,480.00
The global Remicade (infliximab) Drug market size was valued at US$ 2494.5 million in 2023. With growing demand in downstream market, the Remicade (...
颁补迟补濒辞驳:听
LPI
March 2024
Price: USD 3,660.00
The global Digital Hemoglobinometer market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during...
颁补迟补濒辞驳:听
MRRPB5
October 2023
Price: USD 2,900.00
Summary Latanoprost 91制片厂 report provides the newest industry data and industry future trends, allowing you to identify the products and...
颁补迟补濒辞驳:听
ICRW
November 2020
Price: USD 2,960.00
The global Digital Hemoglobinometer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
颁补迟补濒辞驳:听
MRRPB5
April 2024
Price: USD 2,900.00
The global market for Digital Hemoglobinometer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by...
颁补迟补濒辞驳:听
MRRPB5
March 2025
Price: USD 2,900.00
The global Digital Hemoglobinometer market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a...
颁补迟补濒辞驳:听
GIR
July 2025
Price: USD 3,480.00
Branded generics drugs are similar to the innovator products but are marketed and sold under different brand names. In the context of China-US trade...
颁补迟补濒辞驳:听
9Dimen Research
March 2023
Price: USD 3,200.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-伪...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-伪...
颁补迟补濒辞驳:听
MRRPB5
January 2024
Price: USD 2,900.00
Opportunity and Strategy Analysis This report focuses on identifying opportunities and strategies for investing in the global pain management drugs...
颁补迟补濒辞驳:听
Grace Market Data
April 2024
Price: USD 3,800.00
The global Pharmaceutical Grade Ticagrelor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
颁补迟补濒辞驳:听
MRRPB5
July 2024
Price: USD 2,900.00
The global market for Pharmaceutical Grade Ticagrelor was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$...
颁补迟补濒辞驳:听
MRRPB5
October 2024
Price: USD 3,950.00
听
